0 items USD 0.00Search
Your search for "global markets direct amyloidosis pipeline review h2 2017" gave back 83406 results.
Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Hereditary Amyloidosis is one of the amyloidosis disease that is caused by inherited genetic mutation. The “Hereditary Amyloidosis Treatment Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global AL Amyloidosis Therapeutics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
GIR
February 2023
Price: USD 3,480.00
According to our Publisher latest study, the global AL Amyloidosis Therapeutics market size was valued at USD million in 2022 and is forecast to a...
Catalog:
GIR
March 2023
Price: USD 3,480.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Amyloidosis is a clinical disorder caused by extracellular or intracellular deposition of insoluble abnormal amyloid fibrils that affect the normal...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Transthyretin amyloidosis is a slowly progressive disease in which abnormal deposits of a protein called amyloid occur in the body's organs and...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Transthyretin Amyloidosis (ATTR) is an autosomal dominant hereditary disease that occurs due to deposition of variant TTR (transthyretin) protein in...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Transthyretin amyloidosis is a slowly progressive disease in which abnormal deposits of a protein called amyloid occur in the body's organs and...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global Amyloidosis Therapeutics market is projected to grow from US$ 4859.1 million in 2023 to US$ 6605.2 million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Hereditary Amyloidosis is one of the amyloidosis disease that is caused by inherited genetic mutation. Market Analysis and Insights: Global...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
